NAUT Q3 2022 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

NAUTNautilus Biotechnology, Inc.

$289M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$16M

Net Income

-$14M

EPS (Diluted)

$-0.11

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$11M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$359M

Total Liabilities

$34M

Stockholders' Equity

$325M

Cash & Equivalents

$189M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$277,000	+100.0%
Operating Income	-$16M	-$15M	-8.6%
Net Income	-$14M	-$15M	+3.0%